Lucio Iannone

Lucio Iannone is the current director at Khloris Biosciences. Lucio has previous experience working at Cellino, Mozart Therapeutics, Inc, Deka Biosciences, Vesigen Therapeutics, Inc., eGenesis, Inc., Immunitas Therapeutics, Axxam S.p.A, and Khloris Biosciences. Prior to their current position, they were a part of Leaps by Bayer.

Lucio Iannone obtained their Doctor of Philosophy (Ph.D.) in Medicine from Imperial College London. Prior to that, they completed a Master's degree in Medical Biotechnology from Cambridge University Department of Chemical Engineering and Biotechnology. Lucio also holds a Bachelor's degree in Biotechnology from Università degli Studi di Napoli Federico II.